Replies to post #13475 on RespireRx Pharmaceuticals Inc (fka RSPI)

[neuroinv]

<<Tran came from 'XenoPort', not exactly a big name pharma>>

XenoPort has a market cap of $1.2 billion. Not too shabby--but it means he doesn't rely on Big Pharma resources to get clinical trials done. And I have already posted comments from people who know him.

<<Tran might have been the only applicant for the job who didn't back out when the IND was rejected.>>

If you give that more than a few seconds of cursory thought, you'll realize that is absurd.

NeuroInvestment

[alertmeipp]

"All I'm saying is don't extrapolate too far based on a couple iffy data points."

I think you are the one who extrapolate too far! To the negative side ALWAYS.

It's sad to see a poster I once respect posting stuff like that over and over again.